Table 5.
Diagnoses of non-ocular adverse events during the BLINK Study, by treatment category.
| +2.50 D add n (%) |
+1.50 D add n (%) |
Single Vision n (%) |
|
|---|---|---|---|
| Visual symptoms, no obvious cause | 1 (2.9) | 0 (0.0) | 0 (0.0) |
| Non-ocular allergy | 0 (0.0) | 1 (3.4) | 3 (7.0) |
| Non-ocular trauma | 10 (28.6) | 12 (41.4) | 21 (48.8) |
| Headaches (not vision-related) | 6 (17.1) | 3 (10.3) | 6 (14.0) |
| Concussion | 4 (11.4) | 1 (3.5) | 1 (2.3) |
| Systemic disease | 12 (34.3) | 9 (31.0) | 8 (18.6) |
| Mental health issue | 2 (5.7) | 2 (6.9) | 4 (9.3) |
| Can’t categorize | 0 (0.0) | 1 (3.5) | 0 (0.0) |
|
| |||
| Total | 35 | 29 | 43 |